{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:25:23Z","timestamp":1775129123896,"version":"3.50.1"},"reference-count":45,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Context: Conflicting results on the effects of salicylates on glucose tolerance in subjects with normal glucose tolerance or type 2 diabetes have been reported.<\/jats:p><jats:p>Objective: The objective of the study was to investigate the effects of a salicylate derivative (triflusal) on insulin sensitivity and insulin secretion.<\/jats:p><jats:p>Design, Setting, and Participants: This was a double-blind, randomized, crossover study with three treatment periods corresponding to two dose levels of triflusal and placebo in healthy obese subjects.<\/jats:p><jats:p>Main Outcome Measures: Insulin sensitivity and insulin secretion, evaluated through frequently sampled iv glucose tolerance test that was performed after each treatment period, were measured. Insulin secretion was also evaluated in vitro in mice and human islets of Langerhans.<\/jats:p><jats:p>Results: The administration of triflusal led to decreased fasting serum glucose concentration in the study subjects. Insulin sensitivity did not significantly change after each treatment period. Insulin secretion, however, significantly increased in a dose-dependent fashion after each triflusal treatment period. The administration of 800 \u03bcm of the main triflusal metabolite to whole mice islets of Langerhans led to a sustained increase in intracellular calcium concentration level. This was followed by a significantly increase in insulin secretion. In human islets, 200 \u03bcm of 2-hydroxy-4-trifluoromethylbenzoic acid was sufficient to increase insulin release.<\/jats:p><jats:p>Conclusions: The administration of a salicylate compound led to lowering of serum glucose concentration. We suggest that this effect was mediated through increased insulin secretion induced by salicylate directly on the \u03b2-cell.<\/jats:p>","DOI":"10.1210\/jc.2007-1212","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T03:02:00Z","timestamp":1210129320000},"page":"2523-2530","source":"Crossref","is-referenced-by-count":29,"title":["Salicylates Increase Insulin Secretion in Healthy Obese Subjects"],"prefix":"10.1210","volume":"93","author":[{"given":"Jose\u0301-Manuel","family":"Ferna\u0301ndez-Real","sequence":"first","affiliation":[{"name":"Institut d\u2019Investigacio\u0301 Biome\u0301dica de Girona, and CIBEROBN Fisiopatologi\u0301a de la Obesidad y Nutricio\u0301n (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"},{"name":"Department of Diabetes, Endocrinology, and Nutrition (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Lo\u0301pez-Bermejo","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacio\u0301 Biome\u0301dica de Girona, and CIBEROBN Fisiopatologi\u0301a de la Obesidad y Nutricio\u0301n (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"},{"name":"Department of Diabetes, Endocrinology, and Nutrition (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Bele\u0301n","family":"Ropero","sequence":"additional","affiliation":[{"name":"Department of Bioengineering Institute (A.-B.R., A.N.), University of Elche \u201cMiguel Herna\u0301ndez,\u201d Elche, 03202 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Piquer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Hormonal Laboratory (S.P., R.C., R.G.,A.-B.R., A.N.), CIBERDEM Diabetes y Enfermedades Metabo\u0301licas, Hospital Cli\u0301nic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Nadal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Hormonal Laboratory (S.P., R.C., R.G.,A.-B.R., A.N.), CIBERDEM Diabetes y Enfermedades Metabo\u0301licas, Hospital Cli\u0301nic, 08036 Barcelona, Spain"},{"name":"Department of Bioengineering Institute (A.-B.R., A.N.), University of Elche \u201cMiguel Herna\u0301ndez,\u201d Elche, 03202 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Bassols","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacio\u0301 Biome\u0301dica de Girona, and CIBEROBN Fisiopatologi\u0301a de la Obesidad y Nutricio\u0301n (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"},{"name":"Department of Diabetes, Endocrinology, and Nutrition (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Casamitjana","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Hormonal Laboratory (S.P., R.C., R.G.,A.-B.R., A.N.), CIBERDEM Diabetes y Enfermedades Metabo\u0301licas, Hospital Cli\u0301nic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramo\u0301n","family":"Gomis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Hormonal Laboratory (S.P., R.C., R.G.,A.-B.R., A.N.), CIBERDEM Diabetes y Enfermedades Metabo\u0301licas, Hospital Cli\u0301nic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Arnaiz","sequence":"additional","affiliation":[{"name":"Department of Research and Development Clinical Unit (E.A., I.P.), J. Uriach and Company, 08184 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u0303aki","family":"Pe\u0301rez","sequence":"additional","affiliation":[{"name":"Department of Research and Development Clinical Unit (E.A., I.P.), J. Uriach and Company, 08184 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wifredo","family":"Ricart","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacio\u0301 Biome\u0301dica de Girona, and CIBEROBN Fisiopatologi\u0301a de la Obesidad y Nutricio\u0301n (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"},{"name":"Department of Diabetes, Endocrinology, and Nutrition (J.-M.F.-R., A.L.-B., J.B., W.R.),17007 Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613324665800_R1","first-page":"337","volume":"24","author":"Ebstein","journal-title":"Berl Klin Wochenschr"},{"key":"2020071613324665800_R2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/bmj.1.2100.760","article-title":"On the treatment of glycosuria and diabetes mellitus with sodium salicylate.","volume":"1","author":"Williamson","year":"1901","journal-title":"Br Med J"},{"key":"2020071613324665800_R3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.2.5053.1071","article-title":"Aspirin and diabetes mellitus.","volume":"2","author":"Reid","year":"1957","journal-title":"Br Med J"},{"key":"2020071613324665800_R4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.1.5126.897","article-title":"The insulin equivalence of salicylate.","volume":"1","author":"Reid","year":"1959","journal-title":"Br Med J"},{"key":"2020071613324665800_R5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2337\/diab.9.5.392","article-title":"The influence of salicylate on hyperglycemia.","volume":"9","author":"Gilgore","year":"1960","journal-title":"Diabetes"},{"key":"2020071613324665800_R6","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jcem-57-6-1102","article-title":"Aspirin causes tissue insensitivity to insulin in normal man.","volume":"57","author":"Newman","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613324665800_R7","first-page":"279","article-title":"Influence of acetylsalicylic acid on glucose turnover in normal man.","volume":"8","author":"Giugliano","year":"1982","journal-title":"Diabetes Metab"},{"key":"2020071613324665800_R8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00291974","article-title":"Acetyl-salicylic impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.","volume":"28","author":"Bratusch-Marrain","year":"1985","journal-title":"Diabetologia"},{"key":"2020071613324665800_R9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.","volume":"109","author":"Hundal","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071613324665800_R10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK\u03b2.","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"2020071613324665800_R11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-\u03baB by sodium salicylate and aspirin.","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"2020071613324665800_R12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK\u03b2 and NF-\u03baB.","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"2020071613324665800_R13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-\u03b2 links inflammation to obesity-induced insulin resistance.","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"2020071613324665800_R14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jc.2005-1889","article-title":"Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men.","volume":"91","author":"Mohlig","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613324665800_R15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0026-895X(24)23038-8","article-title":"Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.","volume":"55","author":"Fernandez de Arriba","year":"1999","journal-title":"Mol Pharmacol"},{"key":"2020071613324665800_R16","first-page":"681","article-title":"Body mass index (BMI) and percent fat mass. A BMI &gt; 27.5 kg\/m2 could be indicative of obesity in the Spanish population.","volume":"117","author":"Fernandez-Real","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"2020071613324665800_R17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/dc05-2068","article-title":"Burden of infection and insulin resistance in healthy middle-aged men.","volume":"29","author":"Fernandez-Real","year":"2006","journal-title":"Diabetes Care"},{"key":"2020071613324665800_R18","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00125-005-1859-3","article-title":"Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass.","volume":"48","author":"Bosch","year":"2005","journal-title":"Diabetologia"},{"key":"2020071613324665800_R19","first-page":"E769","article-title":"Metabolic regulation of intracellular calcium concentration in mouse pancreatic islets of Langerhans","volume":"267","author":"Nadal","year":"1994","journal-title":"Am J Physiol"},{"key":"2020071613324665800_R20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/01.tp.0000203297.95946.c6","article-title":"Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route.","volume":"81","author":"Conget","year":"2006","journal-title":"Transplantation"},{"key":"2020071613324665800_R21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00006676-199403000-00003","article-title":"Deleterious effect of dithizone-DMSO staining on insulin secretion in rat and human pancreatic islets.","volume":"9","author":"Conget","year":"1994","journal-title":"Pancreas"},{"key":"2020071613324665800_R22","first-page":"343","article-title":"Comparison of the inhibitory effects of acetylsalicylic acid and triflusal on enzymes related to thrombosis.","volume":"237","author":"Garci\u0301a-Rafanell","year":"1979","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2020071613324665800_R23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0952-3278(88)90080-4","article-title":"Effects and interaction studies of triflusal and other salicylic acid derivatives on cyclooxygenase in rats.","volume":"31","author":"De Castellarnau","year":"1988","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2020071613324665800_R24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0306-3623(92)90027-H","article-title":"Triflusal versus aspirin on the inhibition of human platelet and vascular cyclooxygenase.","volume":"23","author":"De la Cruz","year":"1992","journal-title":"Gen Pharmacol"},{"key":"2020071613324665800_R25","first-page":"11","article-title":"Inhibition of thromboxane production and platelet function by triflusal in healthy volunteers.","volume":"4","author":"Albors","year":"1987","journal-title":"Rev Farmacol Clin Exp"},{"key":"2020071613324665800_R26","first-page":"357","article-title":"Effects of triflusal in patients with prosthetic heart valves.","volume":"7","author":"Dominguez","year":"1985","journal-title":"Clin Ther"},{"key":"2020071613324665800_R27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0609.1988.tb00829.x","article-title":"Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.","volume":"40","author":"De la Cruz","year":"1988","journal-title":"Eur J Haematol"},{"key":"2020071613324665800_R28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2337\/diacare.13.11.1114","article-title":"Effects of thromboxane si\u0301ntesis inhibitor triflusal on renal haemodynamics in microalbuminuric diabetic patients.","volume":"13","author":"Esmatjes","year":"1990","journal-title":"Diabetes Care"},{"key":"2020071613324665800_R29","first-page":"155","article-title":"Effects of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.","volume":"284","author":"Garci\u0301a-Rafanell","year":"1986","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2020071613324665800_R30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(97)01518-5","article-title":"Comparison of in vitro effects of triflusal and acetylsalicylic acid on nitric oxide synthesis by human neutrophils.","volume":"343","author":"Sa\u0301nchez de Miguel","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"2020071613324665800_R31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2362.2000.00707.x","article-title":"A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function.","volume":"30","author":"Sa\u0301nchez de Miguel","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"2020071613324665800_R32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","article-title":"4-Trifluromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor \u03baB activation.","volume":"126","author":"Bayo\u0301n","year":"1999","journal-title":"Br J Pharmacol"},{"key":"2020071613324665800_R33","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.2337\/diabetes.51.6.1772","article-title":"Inhibition of interleukin-1\u03b2-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet \u03b2-cell function.","volume":"51","author":"Tran","year":"2002","journal-title":"Diabetes"},{"key":"2020071613324665800_R34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diabetes.47.4.583","article-title":"Evidence for involvement of the proteasome complex (26S) and NF\u03baB in IL-1\u03b2\u2013induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.","volume":"47","author":"Kwon","year":"1998","journal-title":"Diabetes"},{"key":"2020071613324665800_R35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced \u03b2 cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets.","volume":"110","author":"Maedler","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071613324665800_R36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1172\/JCI108827","article-title":"A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus.","volume":"60","author":"Robertson","year":"1977","journal-title":"J Clin Invest"},{"key":"2020071613324665800_R37","first-page":"353","article-title":"Modulation of insulin secretion in normal and diabetic humans by prostaglandin E and sodium salicylate.","volume":"90","author":"Robertson","year":"1977","journal-title":"Trans Assoc Am Physician"},{"key":"2020071613324665800_R38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2337\/diab.27.7.750","article-title":"Restoration of the acute insulin response by sodium salicylate: a glucose dose-related phenomenon.","volume":"27","author":"Chen","year":"1978","journal-title":"Diabetes"},{"key":"2020071613324665800_R39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0026-0495(82)90145-7","article-title":"Modulation of insulin secretion by cyclic AMP and prostaglandin E: the effects of theophylline, sodium salicylate and tolbutamide.","volume":"31","author":"Metz","year":"1982","journal-title":"Metabolism"},{"key":"2020071613324665800_R40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/mol.52.3.398","article-title":"Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets.","volume":"52","author":"Kwon","year":"1997","journal-title":"Mol Pharmacol"},{"key":"2020071613324665800_R41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/bbrc.1996.1622","article-title":"Real time electrochemical detection of 5-HT\/insulin secretion from single pancreatic islets: effect of glucose and K+ depolarization.","volume":"228","author":"Barbosa","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071613324665800_R42","doi-asserted-by":"crossref","first-page":"22265","DOI":"10.1016\/S0021-9258(18)41522-0","article-title":"Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets.","volume":"268","author":"Gilon","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071613324665800_R43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1113\/jphysiol.1979.sp012642","article-title":"The relation between net calcium, alkali cation and chloride movements in red cells exposed to salicylate.","volume":"287","author":"Burgin","year":"1979","journal-title":"J Physiol"},{"key":"2020071613324665800_R44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1054-3589(08)60098-8","article-title":"Uricosuric drugs, with special reference to probenecid and sulfinpyrazone.","volume":"4","author":"Gutman","year":"1966","journal-title":"Adv Pharmacol"},{"key":"2020071613324665800_R45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-3565(24)36490-0","article-title":"Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.","volume":"280","author":"Roch-Ramel","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/7\/2523\/9056919\/jcem2523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/7\/2523\/9056919\/jcem2523.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:50:55Z","timestamp":1738209055000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/7\/2523\/2598525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1212","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,1]]}}}